<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lisa Pangemanan</style></author><author><style face="normal" font="default" size="100%">Irwanto</style></author><author><style face="normal" font="default" size="100%">Margarita M. Maramis</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Mozart K488 Addition Can Improve Depressive-Like Behavior in Rats: In Search of Better Management</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Corticosterone</style></keyword><keyword><style  face="normal" font="default" size="100%">Depressive-like behavior</style></keyword><keyword><style  face="normal" font="default" size="100%">Fluoxetine</style></keyword><keyword><style  face="normal" font="default" size="100%">Hippocampus</style></keyword><keyword><style  face="normal" font="default" size="100%">Melatonin</style></keyword><keyword><style  face="normal" font="default" size="100%">Mozart</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">348-354</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Fluoxetine is one of the medications used for the treatment of depression with several benefits, but some patients have a poor response to the drug. Several studies reported the use of Mozart music (K448) as an alternative therapy for treating the condition, yet the combination of Mozart and fluoxetine remains underexplored. In light of this, this study aims to assess the impact of combined fluoxetine and Mozart (K448) therapy on depressive-like behavior and associated hormonal changes in a rodent model subjected to Chronic Unpredictable Mild Stress (CUMS) conditions.&lt;strong&gt; Materials and Methods: &lt;/strong&gt;The depression-induced animal model received one of these three specified treatments: fluoxetine (F), Mozart (M), or a combination of fluoxetine and Mozart (F+M). The depressive-like behavior was assessed using a 24-hour sucrose preference test (SPT). Additionally, after 21 days of treatment, plasma corticosterone levels and hippocampal melatonin levels were assessed. Statistical analysis using either ANOVA or Kruskal-Wallis tests was then performed.&lt;strong&gt; Results: &lt;/strong&gt;The fluoxetine-Mozart group had higher SPT compared to CUMS group. However, they do not have a better result compared to other groups in terms of corticosterone and melatonin levels with values of respectively. &lt;strong&gt;Conclusion: &lt;/strong&gt;The combined therapy of fluoxetine and Mozart improved depressive-like behavior.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">348</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Lisa Pangemanan&lt;sup&gt;1*&lt;/sup&gt;, Irwanto&lt;sup&gt;2&lt;/sup&gt;, Margarita M. Maramis&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Child Health, Faculty of Medicine, Widya Mandala Catholic University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Child Health, Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Psychiatry, Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muqiemuddin Salim</style></author><author><style face="normal" font="default" size="100%">I Ketut Alit Utamayasa</style></author><author><style face="normal" font="default" size="100%">Roedi Irawan</style></author><author><style face="normal" font="default" size="100%">Irwanto</style></author><author><style face="normal" font="default" size="100%">Azwin Mengindra Putera</style></author><author><style face="normal" font="default" size="100%">Meity Ardiana</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Effect of Cardiac Catheterization Intervention on The Nutritional Status of Children with Acyanotic Congenital Heart Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acyanotic CHD</style></keyword><keyword><style  face="normal" font="default" size="100%">Children</style></keyword><keyword><style  face="normal" font="default" size="100%">Congenital heart disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Interventional cardiac catheterization.</style></keyword><keyword><style  face="normal" font="default" size="100%">Nutritional status</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">338-342</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Intervention is required since malnutrition in children with acyanotic congenital heart disease (CHD) will affect growth, development, and quality of life. Research on the impact of cardiac catheterization on the nutritional health of children with acyanotic CHD is limited, particularly in Indonesia. This study aims to analyze the effect of cardiac catheterization on the nutritional status of children with acyanotic CHD. &lt;strong&gt;Methods: &lt;/strong&gt;A cross-sectional study was conducted between January 2019 and December 2021. The participants of this study were children aged 1-60 months with acyanotic CHD who had undergone cardiac catheterization. We compare the nutritional status of participants in three observation stages, including pre-intervention of catheterization and the 3rd and 6th months post-cardiac catheterization. The parameters of nutritional status are determined according to the mean of Z-scores of weight-for-age (WAZ), length-for-age (LAZ), and weight-for-length (WLZ) of participants. &lt;strong&gt;Results: &lt;/strong&gt;A total of children with acyanotic CHD who underwent catheterization and 49 children were eligible participants. The mean age of children with acyanotic CHD patients who underwent catheterization was 31.51 months, and 89% of them were 1-5 years. Fifty-three percent of participants who underwent cardiac catheterization were male. The most common acyanotic CHD defects were the Patent Ductus Arteriosus (PDA) among 55.1% of participants. Significant differences were found in WAZ, LAZ, and WLZ in the measurement of three observation stages (p&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; Interventional cardiac catheterization affects and enhances the nutritional status of children with acyanotic CHD and may be suggested as an initial therapy to further evaluate the disease.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">338</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Muqiemuddin Salim&lt;sup&gt;1&lt;/sup&gt;, I Ketut Alit Utamayasa&lt;sup&gt;1,*&lt;/sup&gt;, Roedi Irawan&lt;sup&gt;1&lt;/sup&gt;, Irwanto&lt;sup&gt;1&lt;/sup&gt;, Azwin Mengindra Putera&lt;sup&gt;1&lt;/sup&gt;, Meity Ardiana&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Child Health, Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Cardiology and Vascular Medicine, Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>